Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients
Clinical trial NCT01449591 · COMPLETED
Trial details
- NCT number
- NCT01449591
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2012-02-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.